Related Experiment Video
Updated: May 9, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
[Pediatric aids, 30 years later]
1Unité d'immunologie hématologie pédiatrique, hôpital Necker-Enfants-Malades, AP-HP, 149, rue de Sèvres, 75015 Paris, France. stephane.blanche@nck.aphp.fr
Insights
Perinatal HIV-1 transmission risk is nearly zero, with infected children now living stable, asymptomatic lives. Antiretroviral drugs have transformed pediatric AIDS into a manageable chronic condition.
Area of Science:
- Pediatrics
- Epidemiology
- Infectious Diseases
Context:
- Thirty years post-AIDS diagnosis in children, significant progress in prevention and treatment has been achieved.
- The French perinatal epidemiological cohort, established in 1984, has tracked over 18,000 mother-child pairs.
- Early 1980s saw the first descriptions of Acquired Immunodeficiency Syndrome (AIDS) in pediatric populations.
Purpose:
- To outline the advancements in preventing and treating Human Immunodeficiency Virus type 1 (HIV-1) infection in children.
- To highlight the long-term outcomes for children infected with HIV-1 during the perinatal period.
- To document the impact of antiretroviral therapies on the progression of pediatric HIV-1 disease.
Summary:
- Antiretroviral drugs have dramatically reduced mother-to-child HIV-1 transmission to near zero.
- Children infected perinatally now experience a stable, asymptomatic, long-term condition, often achieving satisfactory life quality.
- HIV-1 infection in children has transitioned from a rapidly progressing disease to a manageable chronic condition.
Impact:
- Transformed pediatric HIV-1 care, enabling infected children to mature into adults with chronic, stable health.
- Demonstrates the success of public health interventions and pharmaceutical advancements in managing infectious diseases.
- Provides crucial epidemiological data on the long-term effects of HIV-1 in children and the effectiveness of treatment strategies.
Abstract:
Thirty years after the first descriptions of AIDS in children in May 1983, the risk of viral transmission from mother to child has been reduced to almost zero and the disease in infected children has become an asymptomatic condition, stable in the long-term, thanks to antiretroviral drugs. Unbelievable though it may have seemed until the mid-1990s, children infected during the perinatal period are now growing up to be adults in a chronic, stable, asymptomatic medical condition with often satisfactory personal, family, and social lives. The French perinatal epidemiological cohort, which was set up in 1984 and has included more than 18,000 mother-child pairs to date, traces the steps in this extraordinary revolution in the prevention and treatment of HIV-1 infection in children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Sexually Transmitted Infections

